NCT06797583View on ClinicalTrials.gov

Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Sickle Cell Disease
Interventions
DEVICE

Active Transcranial Photobiomodulation (TPBM)

CytonBrite, 1064nm LED

DEVICE

Sham Transcranial photobiomodulation (TPBM)

Sham condition using a randomized block design involving 2 (TPBM): 1(sham) randomization.

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER